Parkinsonian syndrome after long‐term treatment with clebopride
Identifieur interne : 005F51 ( Main/Exploration ); précédent : 005F50; suivant : 005F52Parkinsonian syndrome after long‐term treatment with clebopride
Auteurs : P. Montagna [Italie] ; A. S. Gabellini [Italie] ; L. Monari [Italie] ; E. Lugaresi [Italie]Source :
- Movement Disorders [ 0885-3185 ] ; 1992.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
- Antiemetic, Antiemetics (adverse effects), Antiemetics (therapeutic use), Benzamides (adverse effects), Benzamides (therapeutic use), Case study, D2 Dopamine receptor, Dopamine antagonist, Dyspepsia (drug therapy), Female, Human, Humans, Long term, Male, Middle Aged, Parkinson Disease, Secondary (chemically induced), Parkinson Disease, Secondary (diagnosis), Stomach Ulcer (drug therapy), Toxicity.
- MESH :
- chemical , adverse effects : Antiemetics, Benzamides.
- chemical , therapeutic use : Antiemetics, Benzamides.
- chemically induced : Parkinson Disease, Secondary.
- diagnosis : Parkinson Disease, Secondary.
- drug therapy : Dyspepsia, Stomach Ulcer.
- Female, Humans, Male, Middle Aged.
Url:
DOI: 10.1002/mds.870070120
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 003D65
- to stream Istex, to step Curation: 003D65
- to stream Istex, to step Checkpoint: 004144
- to stream PubMed, to step Corpus: 004D51
- to stream PubMed, to step Curation: 004D51
- to stream PubMed, to step Checkpoint: 004D24
- to stream Ncbi, to step Merge: 001097
- to stream Ncbi, to step Curation: 001097
- to stream Ncbi, to step Checkpoint: 001097
- to stream Main, to step Merge: 009234
- to stream PascalFrancis, to step Corpus: 003859
- to stream PascalFrancis, to step Curation: 002F65
- to stream PascalFrancis, to step Checkpoint: 003791
- to stream Main, to step Merge: 009367
- to stream Main, to step Curation: 005F51
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Parkinsonian syndrome after long‐term treatment with clebopride</title><author><name sortKey="Montagna, P" sort="Montagna, P" uniqKey="Montagna P" first="P." last="Montagna">P. Montagna</name></author><author><name sortKey="Gabellini, A S" sort="Gabellini, A S" uniqKey="Gabellini A" first="A. S." last="Gabellini">A. S. Gabellini</name></author><author><name sortKey="Monari, L" sort="Monari, L" uniqKey="Monari L" first="L." last="Monari">L. Monari</name></author><author><name sortKey="Lugaresi, E" sort="Lugaresi, E" uniqKey="Lugaresi E" first="E." last="Lugaresi">E. Lugaresi</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:6229E23128F621AB5461211EF2F896D02C50A74A</idno><date when="1992" year="1992">1992</date><idno type="doi">10.1002/mds.870070120</idno><idno type="url">https://api.istex.fr/document/6229E23128F621AB5461211EF2F896D02C50A74A/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">003D65</idno><idno type="wicri:Area/Istex/Curation">003D65</idno><idno type="wicri:Area/Istex/Checkpoint">004144</idno><idno type="wicri:doubleKey">0885-3185:1992:Montagna P:parkinsonian:syndrome:after</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:1557073</idno><idno type="wicri:Area/PubMed/Corpus">004D51</idno><idno type="wicri:Area/PubMed/Curation">004D51</idno><idno type="wicri:Area/PubMed/Checkpoint">004D24</idno><idno type="wicri:Area/Ncbi/Merge">001097</idno><idno type="wicri:Area/Ncbi/Curation">001097</idno><idno type="wicri:Area/Ncbi/Checkpoint">001097</idno><idno type="wicri:doubleKey">0885-3185:1992:Montagna P:parkinsonian:syndrome:after</idno><idno type="wicri:Area/Main/Merge">009234</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:92-0289118</idno><idno type="wicri:Area/PascalFrancis/Corpus">003859</idno><idno type="wicri:Area/PascalFrancis/Curation">002F65</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">003791</idno><idno type="wicri:doubleKey">0885-3185:1992:Montagna P:parkinsonian:syndrome:after</idno><idno type="wicri:Area/Main/Merge">009367</idno><idno type="wicri:Area/Main/Curation">005F51</idno><idno type="wicri:Area/Main/Exploration">005F51</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Parkinsonian syndrome after long‐term treatment with clebopride</title><author><name sortKey="Montagna, P" sort="Montagna, P" uniqKey="Montagna P" first="P." last="Montagna">P. Montagna</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Institute of Neurology Via U. Foscolo 740123 Bologna</wicri:regionArea></affiliation></author><author><name sortKey="Gabellini, A S" sort="Gabellini, A S" uniqKey="Gabellini A" first="A. S." last="Gabellini">A. S. Gabellini</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Institute of Neurology Via U. Foscolo 740123 Bologna</wicri:regionArea></affiliation></author><author><name sortKey="Monari, L" sort="Monari, L" uniqKey="Monari L" first="L." last="Monari">L. Monari</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Institute of Neurology Via U. Foscolo 740123 Bologna</wicri:regionArea></affiliation></author><author><name sortKey="Lugaresi, E" sort="Lugaresi, E" uniqKey="Lugaresi E" first="E." last="Lugaresi">E. Lugaresi</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Institute of Neurology Via U. Foscolo 740123 Bologna</wicri:regionArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="1992">1992</date><biblScope unit="vol">7</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="89">89</biblScope><biblScope unit="page" to="90">90</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">6229E23128F621AB5461211EF2F896D02C50A74A</idno><idno type="DOI">10.1002/mds.870070120</idno><idno type="ArticleID">MDS870070120</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiemetic</term><term>Antiemetics (adverse effects)</term><term>Antiemetics (therapeutic use)</term><term>Benzamides (adverse effects)</term><term>Benzamides (therapeutic use)</term><term>Case study</term><term>D2 Dopamine receptor</term><term>Dopamine antagonist</term><term>Dyspepsia (drug therapy)</term><term>Female</term><term>Human</term><term>Humans</term><term>Long term</term><term>Male</term><term>Middle Aged</term><term>Parkinson Disease, Secondary (chemically induced)</term><term>Parkinson Disease, Secondary (diagnosis)</term><term>Stomach Ulcer (drug therapy)</term><term>Toxicity</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiemetics</term><term>Benzamides</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiemetics</term><term>Benzamides</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Parkinson Disease, Secondary</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Parkinson Disease, Secondary</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Dyspepsia</term><term>Stomach Ulcer</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Antagoniste dopamine</term><term>Antiémétique</term><term>Clébopride</term><term>Etude cas</term><term>Homme</term><term>Long terme</term><term>Récepteur dopaminergique D2</term><term>Toxicité</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader></TEI><affiliations><list><country><li>Italie</li></country></list><tree><country name="Italie"><noRegion><name sortKey="Montagna, P" sort="Montagna, P" uniqKey="Montagna P" first="P." last="Montagna">P. Montagna</name></noRegion><name sortKey="Gabellini, A S" sort="Gabellini, A S" uniqKey="Gabellini A" first="A. S." last="Gabellini">A. S. Gabellini</name><name sortKey="Lugaresi, E" sort="Lugaresi, E" uniqKey="Lugaresi E" first="E." last="Lugaresi">E. Lugaresi</name><name sortKey="Monari, L" sort="Monari, L" uniqKey="Monari L" first="L." last="Monari">L. Monari</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005F51 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005F51 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:6229E23128F621AB5461211EF2F896D02C50A74A
|texte= Parkinsonian syndrome after long‐term treatment with clebopride
}}
| This area was generated with Dilib version V0.6.23. |  |